Dartmouth-Hitchcock Hematology&Oncology Fellowship
@DartmouthHemOnc
Three-year, ACGME accredited Hematology-Oncology fellowship program. Founded in 1960. Part of @DartmouthCancer & @DartmouthHealth #Oncology #Hematology
ID:925781393992495104
http://gme.dartmouth-hitchcock.org/hemonc.html 01-11-2017 17:47:39
251 Tweets
385 Followers
214 Following
Dear Students, Trainees, and Early-Career Oncologists,
We put together these tips to advice on how to plan your ASCO annual meeting!
⭐️ Grow professionally and have fun!
ASCO ASCOTECAG ASCOPres Jacob J. Adashek, DO Cissa Mathias #ASCOConnection
New Hampshire team with Keynote speaker Dr. Glaucomflecken #ASCOAdvocacySummit ASCO
Thank you for pointing out the forgotten patients: the families/caregivers!!!
#DartmouthTeam Geisel School of Medicine at Dartmouth Dartmouth Cancer Center
Visiting my Dartmouth-Hitchcock Hematology&Oncology Fellowship co-fellow Hirotaka Miyashita, MD presenting his work in genomic characteristics of advanced pancreatobiliary cancer by KRAS mutation status Gabriel Brooks at #AACR24 AACR (Section 38 poster 16)
Incredible proud of Jillian Moran MS1 Geisel School of Medicine at Dartmouth She is presenting our experience in validating a whole-transcriptome sequencing assay AACR #AACR24
Jillian is an awardee of the MSR for Underrepresented Populations Conquer Cancer, the ASCO Foundation and this part of her mentorship plan! 👏🏼👏🏼👏🏼
Thank you Cancer Research Institute for featuring me during Women’s Month History
Here is my interview’s link:
cancerresearch.org/stories/womens…
cc Dartmouth Cancer Center Dartmouth-Hitchcock Hematology&Oncology Fellowship
Thank you so much Dr. Anampa for this great talk to our UConn Health and Dartmouth Cancer Center Global Oncology series. Very thought provoking!!
#globaloncology #healthdisparities #CancerResearch
Thank you very much IASLC & Narjust Florez, MD, FASCO for inviting me to speak on this crucial topic bit.ly/BMT24
I hope you enjoy this podcast as much as I did!
There is genetic heterogeneity of NSCLC in LatinAmerica as shown by Oscar Arrieta et al. Biomarker testing is NEEDED
Featuring Spanish-speaking patients and medical experts, including Dr. Ivy Riano Monsalve Ivy Riano, M.D. Dartmouth Cancer Center, CRI's 2024 Spanish-Language Immunotherapy Patient Summit provides the latest info on immunotherapy and clinical trials! Watch now: bit.ly/3OsvldN
Congrats to our fellow Dr. Ivy Riano Ivy Riano, M.D. for participating in the 2024 CRI Spanish-Language Virtual Immunotherapy Patient Summit!!!! 👏🏼👏🏼👏🏼
Our fellows are always committed to patient education!
cancerresearch.org/es/conferencia…
Dartmouth-Hitchcock Hematology&Oncology Fellowship Ivy Riano, M.D. Dartmouth Health Dartmouth Cancer Center Anne Christine Buteau Sign up for the course here! docs.google.com/forms/d/e/1FAI…
Seasons Greetings from Dartmouth Cancer Center Hematology/Oncology Fellows!! May your Holiday Season be merry, full of cheer, and filled with the laughter of loved ones! ❄️❄️Dartmouth Cancer Center
Congratulations to our former fellow Natasha Dhawan, MD for passing her boards exams! Dartmouth Cancer Center 👏🏼👏🏼👏🏼
Officially a board certified internal medicine, hospice and palliative care, hematology, and oncology physician!!!
#quadrupleboarded #pallonc #IMGdream #IMGoncologist
I’m excited to be part of the ASH Minority Recruitment Initiative Celebration this year. The mentor-mentee relationships are so valuable and nourishing. Repping ASH Dartmouth-Hitchcock Hematology&Oncology Fellowship Dartmouth Cancer Center Geisel School of Medicine at Dartmouth National Cancer Institute and #DEI .
#Drugshortages are impacting thousands of individuals w/ cancer, including individuals with cancer in your state @senatorshaheen. Time is not on our side. Please work with your colleagues to mitigate these shortages. #ASCOAdvocacy
Diversity in Clinical Trials Matter! Poster presented at #NACLC23 IASLC
Patients with brain metastasis are underrepresented in lung cancer CT
ASCO/Friends of Cancer Research/FDA Oncology recommended expanding patient access to CT by broadening eligibility criteria ⬇️